How does talimogene laherparepvec promote an anti-tumour immune response?

Talimogene laherparepvec replicates within tumours, produces human GM-CSF and kills tumour cells, releasing tumour-derived antigens that, together with GM-CSF, are thought to promote systemic anti-tumour immunity and an effector T-cell response.